BUSINESS
drugmaker
BUSINESS
Wegovy-maker Novo Nordisk to cut 9,000 jobs in restructuring
BUSINESS
Wegovy maker Novo Nordisk to reduce costs after US$95bil stock loss
BUSINESS
Novo Nordisk’s shares extend losses, erasing nearly all gains since Wegovy launch
BUSINESS
GSK shares fall after sales of top two vaccines disappoint
BUSINESS
Bayer woes pile up as blood thinner drug trial fails
BUSINESS
AstraZeneca commits US$400mil to net-zero goals
BUSINESS
Fujifilm to spend US$5 bil to become global contract drugmaker
WORLD
Desperate Chinese turn to HIV drugs, traditional cures to treat coronavirus
BUSINESS
Johnson & Johnson settles US$24 mil opioid lawsuits to avoid federal trial
BUSINESS
GSK to eliminate 650 jobs
BUSINESS
Glaxo said to seek bids mid-September for US$4 billion India sale
GENERAL